Compared to healthy control cells, DM1 cells showed lower expression in genes associated to myogenic markers (e.g., MYF5, MYOD1, MYF6, SIX1), extracellular matrix components (e.g., COL1A1, COL1A2, COL3A1, COL5A2, LAMA2, FN1), Notch signaling (e.g., HEYL, RBPJ), and cell cycle (e.g., CENPF, CCNA2, CCNB1, CCNB2, CDK1, MKI67) (Fig. 1b, c and Supplementary Data 1). The gene discussed is CDK1; the disease is myotonic dystrophy type 1.